Chromatin immunoprecipitation to analyze DNA binding sites of HMGA2

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Winter, Nina ^a   Nimzyk, Rolf ^a   Bösche, Carolin ^a   Meyer, Anke ^a   Bullerdiek, Jörn ^a,b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; DNA; PRIMER DNA;

ARTICLE; AT RICH SEQUENCE; CANCER CELL CULTURE; CELL STRAIN HCT116; CHROMATIN IMMUNOPRECIPITATION; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DNA FLANKING REGION; DNA FRAGMENTATION; FEMALE; HUMAN; HUMAN CELL; NUCLEOTIDE BINDING SITE; POLYMERASE CHAIN REACTION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; STRUCTURAL BIOINFORMATICS; BINDING SITE; CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA; DNA PRIMERS; HMGA2 PROTEIN; HUMANS;

EID: 79955020072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018837     Document Type: Article

References (46)

1. Fusco A, Fedele M, (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910.
2. Nishino J, Kim I, Chada K, Morrison SJ, (2008) Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135: 227-239.
3. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, et al. (1995) Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10: 436-444.
4. Bustin M, (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237-5246.
5. Reeves R, (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277: 63-81.
6. Bustin M, Reeves R, (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54: 35-100.
7. Li O, Vasudevan D, Davey CA, Droge P, (2006) High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells. Genesis 44: 523-529.
8. Li O, Li J, Droge P, (2007) DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. FEBS Lett 581: 3533-3537.
9. Reeves R, Nissen MS, (1990) The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265: 8573-8582.
10. Solomon MJ, Strauss F, Varshavsky A, (1986) A mammalian high mobility group protein recognizes any stretch of six A.T base pairs in duplex DNA. Proc Natl Acad Sci U S A 83: 1276-1280.
11. Pfannkuche K, Summer H, Li O, Hescheler J, Droge P, (2009) The High Mobility Group Protein HMGA2: A Co-Regulator of Chromatin Structure and Pluripotency in Stem Cells? Stem Cell Rev Rep.
12. Cui T, Leng F, (2007) Specific recognition of AT-rich DNA sequences by the mammalian high mobility group protein AT-hook 2: a SELEX study. Biochemistry 46: 13059-13066.
13. Spencer VA, Sun JM, Li L, Davie JR, (2003) Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 31: 67-75.
14. Dahl JA, Collas P, (2007) Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells 25: 1037-1046.
15. Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, et al. (1997) The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol 4: 657-665.
16. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
17. Summer H, Li O, Bao Q, Zhan L, Peter S, et al. (2009) HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. Nucleic Acids Res 37: 4371-4384.
18. Sgarra R, Tessari MA, Di Bernardo J, Rustighi A, Zago P, et al. (2005) Discovering high mobility group A molecular partners in tumour cells. Proteomics 5: 1494-1506.
19. Sgarra R, Zammitti S, Lo Sardo A, Maurizio E, Arnoldo L, et al. (2009) HMGA molecular network: From transcriptional regulation to chromatin remodeling. Biochim Biophys Acta.
20. Reeves R, Beckerbauer L, (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519: 13-29.
21. Cleynen I, Brants JR, Peeters K, Deckers R, Debiec-Rychter M, et al. (2007) HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol Cancer Res 5: 363-372.
22. Perrone G, Vincenzi B, Zagami M, Santini D, Panteri R, et al. (2007) Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. Mod Pathol 20: 344-351.
23. Li T, Su Y, Mei Y, Leng Q, Leng B, et al. (2010) ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 90: 234-244.
24. Dassoulas K, Gazouli M, Theodoropoulos G, Christoni Z, Rizos S, et al. (2010) Vascular endothelial growth factor and endoglin expression in colorectal cancer. J Cancer Res Clin Oncol 136: 703-708.
25. Jessup JM, Lavin PT, Andrews CW Jr, Loda M, Mercurio A, et al. (1995) Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum 38: 1257-1264.
26. Yasui Y, Tanaka T, (2009) Protein expression analysis of inflammation-related colon carcinogenesis. J Carcinog 8: 10.
27. Zhao Y, Zhang X, Guda K, Lawrence E, Sun Q, et al. (2010) Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc Natl Acad Sci U S A 107: 2592-2597.
28. Reddy SD, Ohshiro K, Rayala SK, Kumar R, (2008) MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68: 8195-8200.
29. Urruticoechea A, Aguilar H, Sole X, Capella G, Martin LA, et al. (2008) Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer. Breast Cancer Res Treat 109: 463-470.
30. Rohozinski J, Anderson ML, Broaddus RE, Edwards CL, Bishop CE, (2009) Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers. PLoS One 4: e5064.
31. Takeuchi T, Watanabe Y, Takano-Shimizu T, Kondo S, (2006) Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn 235: 2449-2459.
32. Cleynen I, Van de Ven WJ, (2008) The HMGA proteins: a myriad of functions (Review). Int J Oncol 32: 289-305.
33. Soule HD, Vazguez J, Long A, Albert S, Brennan M, (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416.
34. Rogalla P, Kazmierczak B, Rohen C, Trams G, Bartnitzke S, et al. (1994) Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging. Cancer Genet Cytogenet 77: 19-25.
35. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, et al. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086.
36. Goretzki PE, Frilling A, Simon D, Roeher HD, (1990) Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res 118: 48-63.
37. Tanaka J, Ogura T, Sato H, Hatano M, (1987) Establishment and biological characterization of an in vitro human cytomegalovirus latency model. Virology 161: 62-72.
38. Belge G, Kazmierczak B, Meyer-Bolte K, Bartnitzke S, Bullerdiek J, (1992) Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation T(3;12) is not sufficient for direct immortalization. Cell Biol Int Rep 16: 339-347.
39. Namba H, Hara T, Tukazaki T, Migita K, Ishikawa N, et al. (1995) Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res 55: 2075-2080.
40. Estour B, Van Herle AJ, Juillard GJ, Totanes TL, Sparkes RS, et al. (1989) Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol 57: 167-174.
41. Smith SD, Shatsky M, Cohen PS, Warnke R, Link MP, et al. (1984) Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res 44: 5657-5660.
42. Brattain MG, Brattain DE, Sarrif AM, McRae LJ, Fine WD, et al. (1982) Enhancement of growth of human colon tumor cell lines by feeder layers of murine fibroblasts. J Natl Cancer Inst 69: 767-771.
43. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
44. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, et al. (2005) Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85: 1040-1050.
45. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, et al. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res 12: 1611-1618.
46. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.